Full description
Baseline randomisaton data (Hb, MCV, age gender, primary hospital diagnosis), risk factors at randomisation, randomisation allocation and treatment received, Hb at 1 and 6-9 months follow up, other iron supplementation during follow up.Notes
HeSANDA 1.0.0Issued: 2026
Spatial Coverage And Location
text: Northern Territory, Australia
User Contributed Tags
Login to tag this record with meaningful keywords to make it easier to discover
Other Information
National Health and Medical Research Council
Crossref Funder ID : https://doi.org/10.13039/501100000925
Identifiers
- DOI : 10.25913/2KVM-Z442